This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Molinero, Luciana
| Item Type | Name |
|
Academic Article
|
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.
|
|
Academic Article
|
Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up: A Phase 1b Clinical Trial.
|
|
Academic Article
|
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
|
|
Academic Article
|
Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab.
|
|
Academic Article
|
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial.
|
|
Academic Article
|
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.
|
|
Academic Article
|
Prevalence Study of PD-L1 SP142 Assay in Metastatic Triple-negative Breast Cancer.
|
|
Academic Article
|
Enrichment of circulating tumor-derived extracellular vesicles from human plasma.
|
|
Academic Article
|
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study.
|
|
Academic Article
|
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer.
|
|
Academic Article
|
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis.
|
|
Academic Article
|
Corrigendum to 'First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis': Annals of Oncology 2021; volume 32: 983-993.
|
|
Academic Article
|
Corrigendum to 'First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis': Annals of Oncology 2021; 32: 983-993.
|
|
Concept
|
Triple Negative Breast Neoplasms
|
- Triple Negative Breast Neoplasms